Simulations Plus acquisition by Altaris closes at $18.50 per share
SLP•Altaris completed its acquisition of Simulations Plus for $18.50 per share in cash, taking the company private and ending its Nasdaq Global Select Market trading.
1. Acquisition closes
Altaris completed its acquisition of Simulations Plus, paying $18.50 per share in cash. Simulations Plus became privately held, and trading of its common stock on the Nasdaq Global Select Market ended.
2. Software platform
The deal, first disclosed on June 16, 2026, pairs Simulations Plus with Altaris-owned Chemical Computing Group to build a broader drug discovery and development software platform.


